Results 31 to 40 of about 10,538,307 (206)

A One-Step Immunoassay for Carbohydrate Antigen 19-9 by Biosensor Based on Imaging Ellipsometry

, 2011
 Cancer markers can offer much more information for developing or developed cancers. Simple and short-time assay of cancer biomarker is essential for clinic diagnosis and management.
Huang CH (黄承洪), Jin G (靳刚), Chen YY (陈艳艳)   +2 more
core   +2 more sources

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study

BMC Cancer, 2023
Background This study aimed to investigate the association between baseline serum tumor markers (STMs) (carcinoembryonic antigen [CEA], neuron-specific enolase [NSE], cytokeratin-19 fragment [CYFRA21-1], carbohydrate antigen 19–9 [CA19-9], and ...
Jian Huang, Yi Xiao, Yubin Zhou, Huiyin Deng, Zihao Yuan, Longyan Dong, Jun Lan, Xiane Li, Gaijiao Liu, Hao Hu, Shaohong Huang, Xiongwen Yang   +11 more
doaj   +1 more source

The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer

Open Medicine, 2023
This study aimed to explore the value of color Doppler ultrasonography combined with carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) in differential diagnosis of gastric stromal tumor (GST) and gastric cancer (GC).
Cheng Xinyu, Xia Jianguo, Xu Qi, Gui Huawei   +3 more
doaj   +1 more source

Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection. [PDF]

, 2001
The carbohydrate antigen 19-9 (CA 19-9), a determinant (sialylated lacto-N-fucopentaose 119) of a circulating oligosaccharide antigen, is a frequently used tumor marker. Echinococcus spp.
Cerny, A, Gottstein, Bruno, Kretschmer, Robert, Cerny, T, Pfister, M   +4 more
core   +2 more sources

Correlation between serum carbohydrate antigen 19-9 levels and computed tomography severity score in patients with nontuberculous mycobacterial pulmonary disease

Scientific Reports, 2021
There is no validated clinical biomarker for disease severity or treatment response for nontuberculous mycobacterial pulmonary disease (NTM-PD). We investigated the correlation between elevated serum carbohydrate antigen (CA) 19-9 levels and NTM-PD ...
Kangjoon Kim, Seung Hyun Yong, Su Hwan Lee, Sang Hoon Lee, Ah Young Leem, Song Yee Kim, Kyungsoo Chung, Eun Young Kim, Ji Ye Jung, Moo Suk Park, Young Sam Kim, Hye-Jeong Lee, Young Ae Kang   +12 more
doaj   +1 more source

Central nervous system mature teratoma producing carbohydrate antigen 19-9: illustrative case [PDF]

, 2022
BACKGROUND: Central nervous system (CNS) mature teratoma is a rare disease with symptoms that can vary according to tumor location. Most lesions are benign; rarely, malignancy can develop in any of the somatic components. Elevated levels of tumor markers
Takeuchi, Yasuhide, Yohei Mineharu, Sachiko Minamiguchi, Susumu Miyamoto, Haga, Hironori, Shu Takeuchi, Tanji, Masahiro, Mineharu, Yohei, Hironori Haga, Arakawa, Yoshiki, Masahiro Tanji, Yoshiki Arakawa, Yasuhide Takeuchi, Minamiguchi, Sachiko, Miyamoto, Susumu, Takeuchi, Shu   +15 more
core   +1 more source

Tumor marker elevations in chronic kidney disease: a retrospective study [PDF]

PeerJ
Aim To investigate the changes in tumor markers such as carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA15-3), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 72-4 (CA72-4), pro-gastrin-releasing peptide (proGRP), and human ...
Liuxia You, Zhongying Xu, Qiaoling Liu, Guoming Jin, Changting Wang   +4 more
doaj   +2 more sources

Two Cases of the Same Family with the Unusual Elevation of CA19-9 Levels

Acta Médica Portuguesa, 2014
Introduction: Serum carbohydrate associated antigen (CA19-9) is widely used marker in clinical practice and shows small increases in a few benign diseases.
Metin Uyanik, Erdim Sertoglu, Muhittin A. Serdar, Fevzi N. Aydin, Taner Ozgurtas, Ismail Kurt   +5 more
doaj   +1 more source

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer

Discover Oncology, 2023
Background Carbohydrate antigen 19–9 (CA19-9) is the most widely used biomarker for pancreatic cancer. Since CA19-9 closely correlates with patient outcome and tumor stage in pancreatic cancer, the deciphering of CA19-9 biosynthesis provides a potential ...
Chen Liu, Shengming Deng, Zhiwen Xiao, Renquan Lu, He Cheng, Jingjing Feng, Xuxia Shen, Quanxing Ni, Weiding Wu, Xianjun Yu, Guopei Luo   +10 more
doaj   +1 more source

REPORT OF A PATIENT WITH A HUGE LIVER CYST WHO HAD A HIGH SERUM LEVEL OF CARBOHYDRATE ANTIGEN 19-9 (CA19-9)

The journal of the Japanese Practical Surgeon Society, 1987
The patient was a 65-year-old woman who was admitted with an abdominal mass. CT-scans showed a huge liver cyst that was homogeneous except for one part of the wall which was calfified. Ultrasonograms showed an irregular floating structure in the cyst. Inferior vena cava (IVC) angiograms showed that the IVC was compressed by the cyst and that collateral
TANAKA, Hiromu, SAKAI, Katsuji, KINOSHITA, Hiroaki, HIROHASHI, Kazuhiro, TSUJI, Yasutoshi, KOBO, Syoji, TEI, Noritaka, IWASA, Ryutaro, LEE, Mitsuharu, NAKATA, Koji   +9 more
openaire   +2 more sources